Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.65% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Neuropace
NPCE
$503M
| $614K | ﹤0.01% |
81,200
-38,771
| -32% | -$391K |
|
2602
RadNet
RDNT
$6.05B
| $613K | ﹤0.01% |
10,400
-20,700
| -67% | -$1.12M |
|
2603
Merck
MRK
$334B
| $610K | ﹤0.01% |
4,915
-195,287
| -98% | -$25.2M |
|
2604
ImmuCell
ICCC
$92.9M
| $609K | ﹤0.01% |
125,589
+700
| +0.6% | +$3.37K |
|
|
SHCO
2605
DELISTED
Soho House & Co
SHCO
| $609K | ﹤0.01% |
114,702
+9,502
| +9% | +$50.9K |
|
2606
Toro Company
TTC
$9.32B
| $608K | ﹤0.01% |
+6,500
| New | +$573K |
|
|
SYRS
2607
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $606K | ﹤0.01% |
117,435
-2,400
| -2% | -$12.6K |
|
2608
Dimensional International Small Cap Value ETF
DISV
$5.18B
| $605K | ﹤0.01% |
22,500
+400
| +2% | +$11K |
|
2609
National Bankshares
NKSH
$271M
| $604K | ﹤0.01% |
21,370
+500
| +2% | +$14.8K |
|
2610
Tiptree Inc
TIPT
$674M
| $604K | ﹤0.01% |
36,600
-2,737
| -7% | -$45.8K |
|
2611
Coinshares Bitcoin ETF
BRRR
$395M
| $603K | ﹤0.01% |
+35,500
| New | +$660K |
|
2612
Idaho Strategic Resources
IDR
$503M
| $599K | ﹤0.01% |
60,750
+12,050
| +25% | +$112K |
|
|
TERN
2613
DELISTED
Terns Pharmaceuticals
TERN
| $596K | ﹤0.01% |
+87,500
| New | +$530K |
|
2614
Sprinklr
CXM
$1.62B
| $595K | ﹤0.01% |
61,800
-316,400
| -84% | -$3.54M |
|
2615
Vanguard Consumer Discretionary ETF
VCR
$6.11B
| $594K | ﹤0.01% |
1,901
-499
| -21% | -$153K |
|
2616
Oramed Pharmaceuticals
ORMP
$184M
| $593K | ﹤0.01% |
230,800
+108,700
| +89% | +$258K |
|
2617
Altisource Portfolio Solutions
ASPS
$64.9M
| $591K | ﹤0.01% |
52,403
-400
| -0.8% | -$5.56K |
|
2618
Data Storage Corp
DTST
$7.36M
| $590K | ﹤0.01% |
89,900
+39,900
| +80% | +$236K |
|
|
IAS
2619
DELISTED
Integral Ad Science
IAS
| $588K | ﹤0.01% |
60,500
-4,300
| -7% | -$41.2K |
|
2620
Farmers National Banc Corp
FMNB
$966M
| $586K | ﹤0.01% |
46,884
-7,100
| -13% | -$87.3K |
|
2621
iShares Global Healthcare ETF
IXJ
$4.2B
| $585K | ﹤0.01% |
6,300
-14,736
| -70% | -$1.34M |
|
2622
Hamilton Beach Brands
HBB
$447M
| $585K | ﹤0.01% |
34,007
+15,007
| +79% | +$305K |
|
2623
Citi Trends
CTRN
$615M
| $584K | ﹤0.01% |
+27,457
| New | +$630K |
|
2624
Schwab International Small-Cap Equity ETF
SCHC
$5.71B
| $584K | ﹤0.01% |
16,400
+10,700
| +188% | +$381K |
|
2625
Lineage Cell Therapeutics
LCTX
$273M
| $582K | ﹤0.01% |
583,622
+53,022
| +10% | +$58.6K |
|
Similar funds
Jim Simons's Q2 2024 Portfolio in Review
As of Q2 2024, Jim Simons held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $4.49B in Q2 2024, closing 674 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Broadcom worth $472M.
- Jim Simons's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Jim Simons added most to Apple in Q2 2024, an estimated $244M increase.
- Jim Simons's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Jim Simons fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Jim Simons's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Jim Simons opened 463 new positions and closed 674 in Q2 2024.
- Jim Simons's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.